Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sedana Medical ABFRA:7D2A +3.63%69 Gross Margin % is 72.98% as of Jun. 2026, which is 3% above its 10-year median of 70.70. GuruFocus rates FRA:7D2A with a GF Score™ of 69/100 and a GF Value™ of €1.47. The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Sedana Medical AB ranks better than 82.75% on this metric.
The historical rank and industry rank for Sedana Medical AB's Gross Margin % or its related term are showing as below:
FRA:7D2A'
s Gross Margin % Range Over the Past 10 Years
Min: 62.71 Med: 70.7 Max: 76.56
Current: 71.98
During the past 11 years, the highestGross Margin % of Sedana Medical AB was 76.56%. The lowest was 62.71%. And the median was 70.70%.
FRA:7D2A's Gross Margin % is ranked better than 82.75% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs FRA:7D2A: 71.98
Sedana Medical AB had a gross margin of 72.98% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sedana Medical AB was 2.30% per year.
Sedana Medical AB (FRA:7D2A) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sedana Medical AB had a gross margin of 72.98% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sedana Medical AB Gross Margin % Related Terms
Sedana Medical AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sedana Medical AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7D2A vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Sedana Medical AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sedana Medical AB (FRA:7D2A) has a Gross Margin % of 72.98% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sedana Medical AB and its competitors. This is near median its historical median of 70.70. Over the past decade, Sedana Medical AB's Gross Margin % has ranged from 62.71 to 76.56. According to the industry distribution chart, Sedana Medical AB ranks #139 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 17.2%.
Is Sedana Medical AB's Gross Margin % too high?
Sedana Medical AB's current Gross Margin % of 72.98% is near median its 10-year median of 70.70. Over the past 10 years, this metric has ranged from a low of 62.71 to a high of 76.56. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Sedana Medical AB's value of 72.98% is 40% above this industry median. Based on the distribution chart, Sedana Medical AB ranks #139 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sedana Medical AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #139 out of 806 companies for Gross Margin %. This places Sedana Medical AB in the top 17% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.12. Sedana Medical AB's value of 72.98% is 40% above this benchmark. Historically, Sedana Medical AB's own Gross Margin % has ranged from 62.71 to 76.56 over the past decade. While the company's 10-year median is 70.70 vs. the industry median of 52.12, Sedana Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sedana Medical AB's current Gross Margin % of 72.98% is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sedana Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current Gross Margin % is 72.98%, which is near median its own 10-year median of 70.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Sedana Medical AB (FRA:7D2A) has a current Gross Margin % of 72.98%. The stock's GF Value™ is €1.47, compared to a current price of €0.86 — trading 41.7% below its estimated fair value. The current Gross Margin % is 72.98%, which is near median its 10-year median of 70.70 and 40% above the Medical Devices & Instruments industry median of 52.12. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sedana Medical AB (FRA:7D2A), the current Gross Margin % is 72.98% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (FRA:7D2A) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of €0.86 is trading 41.7% below its estimated GF Value™ of €1.47.
Key valuation signals for FRA:7D2A:
Gross Margin %: 72.98% (near median its 10-year median of 70.70)
GF Value™: €1.47 vs. price of €0.86 (41.7% below fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#139 of 806)
No single metric tells the full story. See the FRA:7D2A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for FRA:7D2A
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7D2A has been successfully added to your 
